Adalank Spray contains Adalank, a synthetic peptide described by suppliers as a modified analog of Selank, the heptapeptide Thr-Lys-Pro-Arg-Pro-Gly-Pro. Supplier descriptions of the modification are inconsistent, and no peer-reviewed structural characterization or registry record for Adalank was located.

Adalank itself has not been characterized in the indexed literature. The parent peptide Selank is reported to inhibit enkephalin-degrading peptidases in serum and to alter expression of genes associated with GABAergic neurotransmission and cytokine signaling in rodent tissue.

Adalank Spray is supplied as a pre-dissolved aqueous solution of the peptide in a 15 mL metered dispensing container, a format intended to simplify aliquoting and laboratory handling without a separate dissolution step. Keep the container sealed and refrigerated, protected from light, and avoid freezing; identity and purity of the dissolved material should be confirmed analytically before use.

Research use only. This material is sold for in-vitro laboratory research and development purposes exclusively. It is not a drug, food, or dietary supplement, has not been evaluated by the FDA, and must not be used in humans or animals.